OSX 5.00% 3.8¢ osteopore limited

Ann: Non-Renounceable Entitlement Offer Extension, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 662 Posts.
    lightbulb Created with Sketch. 90
    Thanks for that. I had not applied for shares in the offer - afraid that it might be throwing more money away. Now the extension gives another chance. Their hype claims that their products are better than those of competitors. If so, quality probably will win in the long term. I guess one special product is the Osteomesh for reshaping noses - possibly a big market for that in Asia.
    I wonder whether other holders are worried about the competition - have you done due diligence (I am afraid I did not research enough), or do you just go along with the idea that Osteopore can win market share everywhere, and has the special nose altering mesh, which may be the most profitable product.
 
watchlist Created with Sketch. Add OSX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.